FDA Inspection 1217938 — Fareva Richmond, Inc.

Fareva Richmond, Inc. — FEI 1120199

The FDA completed an inspection of Fareva Richmond, Inc. on September 18, 2023 in Henrico, VA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 7 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 18, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Henrico, VA (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
113321 CFR 211.25(a)GMP Training Frequency
121521 CFR 211.67(b)Written procedures not established/followed
163721 CFR 211.130(e)Packaging line inspection after use
179021 CFR 211.80(b)Handling and Storage to Prevent Contamination
191221 CFR 211.166(a)Written program not followed
202721 CFR 211.192Investigations of discrepancies, failures